Diagnostics group Eurofins gets US 'EUA' approval for home-based COVID-19 Test
Results are reviewed by a licensed physician and provided via email within 24 hours of sample receipt
Paris, October 19
Laboratory testing and diagnostics company Eurofins said its new at-home COVID nasal testing product had received ‘Emergency Use Approval’ (EUA) status from the US Food & Drug Administration regulatory body.
Eurofins said the EUA authorised self-collection kit gives consumers a convenient and quick option to test from the comfort of their home, with results reviewed by a licensed physician and provided via email within 24 hours of sample receipt.
Worldwide coronavirus cases crossed 40 million on Monday, according to a Reuters tally, as the onset of winter in the northern hemisphere fuelled a resurgence in the spread of the disease. Reuters
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Already a Member? Sign In Now
